PMID: 25762616Mar 13, 2015Paper

Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers

Oncotarget
Feng LiGautam Sethi

Abstract

Platinum compounds such as cisplatin and carboplatin are frequently used as the first-line chemotherapy for the treatment of the head and neck squamous cell carcinoma (HNSCC). In the present study, we investigated whether garcinol, a polyisoprenylated benzophenone can chemosensitize HNSCC to cisplatin. We found that garcinol inhibited the viability of a panel of diverse HNSCC cell lines, enhanced the apoptotic effect of cisplatin, suppressed constitutive as well as cisplatin-induced NF-κB activation, and downregulated the expression of various oncogenic gene products (cyclin D1, Bcl-2, survivin and VEGF). In vivo study showed that administration of garcinol alone (0.5 mg/kg body weight, i.p. five times/week) significantly suppressed the growth of the tumor, and this effect was further increased by cisplatin. Both the markers of proliferation index (Ki-67) and microvessel density (CD31) were downregulated in tumor tissues by the combination of cisplatin and garcinol. The pharmacokinetic results of garcinol indicated that good systemic exposure was achievable after i.p. administration of garcinol at 0.5 mg/kg and 2 mg/kg with mean peak concentration (Cmax) of 1825.4 and 6635.7 nM in the mouse serum, respectively. Overall, our res...Continue Reading

References

Feb 26, 2000·Journal of Agricultural and Food Chemistry·F YamaguchiH Nakazawa
Apr 12, 2000·International Journal of Radiation Oncology, Biology, Physics·A Trotti
Feb 24, 2001·Cancer Metastasis Reviews·S Gately
Feb 28, 2001·Apoptosis : an International Journal on Programmed Cell Death·H Eichholtz-Wirth, D Sagan
Jun 16, 2001·Head & Neck·G P BrowmanUNKNOWN Cancer Care Ontario Practice Guideline Initiative Head and Neck Cancer Disease Site Group
Feb 22, 2002·Journal of Cellular Physiology·Yang Cao, Stephen M Prescott
May 7, 2002·Nature Reviews. Cancer·Mikala Egeblad, Zena Werb
Apr 20, 2004·Cancer Cell·Li MaoVassiliki A Papadimitrakopoulou
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ezra E W CohenEverett E Vokes
May 28, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Ping L ZhangRobert E Brown
Sep 26, 2006·International Journal of Cancer. Journal International Du Cancer·Alok MishraBhudev C Das
Nov 7, 2006·Cancer Treatment Reviews·Cara A Rabik, M Eileen Dolan
Mar 1, 2007·Nature Clinical Practice. Oncology·Tanguy Y SeiwertEverett E Vokes
Mar 6, 2007·Critical Reviews in Oncology/hematology·David J Stewart
May 20, 2008·Lancet·Athanassios ArgirisRobert L Ferris
Sep 23, 2008·Oral Oncology·Alfredo A MolinoloJ Silvio Gutkind
Nov 29, 2008·BMC Medical Genomics·Panagiotis A KonstantinopoulosDimitrios Spentzos
May 9, 2009·Chemical Reviews·Gordon M CraggDavid J Newman
May 19, 2009·Trends in Pharmacological Sciences·Gautam Sethi, Vinay Tergaonkar
Jul 3, 2009·Current Opinion in Pharmacology·Frederick WangCarter Van Waes
Sep 4, 2009·Journal of Hematology & Oncology·Subhash PadhyeFazlul H Sarkar
Oct 24, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C H ChungB A Murphy
Apr 8, 2010·Molecular Cancer Therapeutics·Sahdeo PrasadBharat B Aggarwal
Jun 19, 2010·Expert Opinion on Emerging Drugs·Christopher Fung, Jennifer R Grandis
Jul 14, 2010·Nature Cell Biology·Hsiangling TeoVinay Tergaonkar
Apr 5, 2011·Nutrition and Cancer·Mansi A Parasramka, Smiti V Gupta
May 18, 2011·Archives of Otolaryngology--head & Neck Surgery·Waleed M AbuzeidThomas E Carey
Sep 6, 2011·Oncogene·L GalluzziG Kroemer
Oct 11, 2011·Bioscience Reports·Gautam SethiVinay Tergaonkar

❮ Previous
Next ❯

Citations

Aug 15, 2018·International Journal of Molecular Sciences·Abhishek Manoj RanawareAjaikumar B Kunnumakkara
Dec 19, 2018·International Journal of Molecular Sciences·Jeong-Hyeon KoKwang Seok Ahn
Mar 16, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Min Hee YangKwang Seok Ahn
Feb 6, 2019·International Journal of Molecular Sciences·Vaishali AggarwalMukerrem Betul Yerer
Oct 23, 2019·International Journal of Molecular Sciences·Naoki SuenagaHirofumi Jono
Jul 14, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Seok KimTaeg Kyu Kwon
Feb 20, 2019·International Journal of Molecular Sciences·Mohd FarhanAamir Ahmad
Feb 23, 2019·Cancers·Bethsebie Lalduhsaki SailoAjaikumar Bahulayan Kunnumakkara
Aug 31, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Young Yun JungKwang Seok Ahn
Dec 15, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Sadhna Aggarwal, Satya N Das
Mar 31, 2019·International Journal of Molecular Sciences·Sungjin ChungHo-Shik Kim
May 6, 2019·Cancers·Samantha Kah Ling OngAnupam Bishayee
Jul 8, 2020·International Journal of Molecular Sciences·Young Yun JungKwang Seok Ahn
Jul 2, 2020·Seminars in Cancer Biology·Elina KhatoonAjaikumar B Kunnumakkara
Dec 18, 2020·Life Sciences·Semim Akhtar AhmedAjaikumar B Kunnumakkara
Apr 4, 2021·International Journal of Molecular Sciences·Kumar RishabhAjaikumar B Kunnumakkara
Sep 28, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Juan ZhaoLong Li
Jan 26, 2016·Pharmacology & Therapeutics·Stephanie KaypeeTapas K Kundu
Jun 26, 2021·IUBMB Life·Sosmitha GirisaAjaikumar B Kunnumakkara
Jul 11, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Sepideh MirzaeiGautam Sethi
Feb 21, 2018·Chemical Reviews·Xing-Wei YangGang Xu
Nov 23, 2021·Phytotherapy Research : PTR·Yudong ZhengKwang Seok Ahn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.